Corticosteroid. Budesonide 2 mg. Canister with 14 X of 1.2 g
One actuation of 2 mg /d
Tmt of act. ulcerative colitis limited to the rectum and the sigmoid colon
C/I: Hypersens. /hepatic cyrrhosis
Anti-CD20, Human Monoclonal Antibody. Ocrelizumab 40 mg/ml. Vial. 1 X 920 mg for SC inject.
single 23 mL in the abdomen over approx. 10 minutes every 6 months.
For adults with relapsing or primary progress. forms of multiple sclerosis.
C/I:Hypersens. Active HBV infection/ A hist. of life-threatening admin. reaction to ocrelizumab
Sodium Chloride 5%. Eye drops. solut., 10 ml
To use as needed
* Visual discomfort, burning and eye irritat. caused by corneal oedema
* In the case of abnormal fluid accumulat. caused by corneal oedema, with or without inflamm. or blunt trauma after refractive or ophthalmic surgery, cataracts, transplants, retinal detachments, corneal transplants, corneal endothelial decompensation and in all dystrophic, mechanical, toxic and inflammatory corneal decompensations.
Antivirals, Protease Inhibitors. nirmatrelvir 150 mg, Ritonavir 100 mg. 20 X FC pink tabs contain.150 mg of nirmatrelvir.
10 XFC white to off white tabs contain.100 mg of ritonavir.
Recomm. dosage is 300 mg nirmatrelvir (two 150 mg tablets) with 100 mg ritonavir (one 100 mg tablet) all taken together orally every 12 hours for 5 days. This drug should be admin. as soon as possible after a diagnosis of COVID-19 has been made and within 5 days of symptom onset.
Tmt. of confirmed coronavirus dis. 2019 (COVID-19) in adults
who do not require suppl. oxygen and who are at incr. risk for progressing to sev. COVID-19
C/I: Hypersens.
Medic. prod. listed below are a guide and not considered a comprehensive list of all possible medic. prod. that are contraind. with this drug.
Medic. prod. that are highly dependent on CYP3A for clearance and for which elevated plasma concentr. are associated with serious and/or life-threatening reactions.
Alpha1-adrenoreceptor antagonist: alfuzosin
Antianginal: ranolazine
Antiarrhythmic: dronedarone, propafenone, quinidine
Anticancer drugs: neratinib, venetoclax
Anti-gout: colchicine
Antihistamines: terfenadine
Antipsychotics/neuroleptics: lurasidone, pimozide, quetiapine
Benign prostatic hyperplasia medicinal products: silodosin
Cardiovascular medicinal products: eplerenone, ivabradine
Ergot derivatives: dihydroergotamine, ergonovine, ergotamine, methylergonovine
GI motility agents: cisapride
Immunosuppressants: voclosporin
Lipid-modifying agents:
o HMG Co-A reductase inhibitors: lovastatin, simvastatin
o Microsomal triglyceride transfer protein (MTTP) inhibitor: lomitapide
Migraine medicinal products: eletriptan
Mineralocorticoid receptor antagonists: finerenone
Neuropsychiatric agents: cariprazine
Opioid antagonists: naloxegol
PDE5 inhibitor: avanafil, sildenafil, tadalafil, vardenafil
Sedative/hypnotics: clorazepate, diazepam, estazolam, flurazepam, oral midazolam and triazolam
Vasopressin receptor antagonists: tolvaptan
Medic. prod. that are potent CYP3A inducers where significant. reduced nirmatrelvir/ritonavir plasma concentr. may be associated with the potential for loss of virologic response and possible resistance.
Antibiotics: rifampicin, rifapentine
Anticancer drugs: apalutamide, enzalutamide
Anticonvulsants: carbamazepine, phenobarbital, phenytoin, primidone
Cystic fibrosis transmembrane conductance regulator potentiators: lumacaftor/ivacaftor
Herbal products: St. John's wort (Hypericum perforatum)
This drug cannot be started immediately after discontinuation of CYP3A4 inducers due to the delayed offset of the recently discontinued CYP3A4 inducer.
Centrally Acting Sympathomimetics. Lisdexamfetamine 10 mg/ml. Bottle, oral sol. 100 ml
ADHD: starting dosage in adults and ped. pts 6 years and older is 30 mg (equivalent to 3 ml) once/d in the morning. Dosage may be adj. in incr. of 10 mg (equivalent to 1 ml) or 20 mg (equivalent to 2 ml) at approx. weekly intervals up to max. dosage of 70 mg (equivalent to 7 ml) once/d.
Moderate to Severe BED in Adults: starting dosage in adults is 30 mg (equivalent to 3 ml) once /d to be titrated in incr. of 20 mg (equivalent to 2 ml) at approx. weekly intervals to achieve target dose of 50 to 70 mg (equivalent to 5 ml to 7 ml) once daily. The max. dosage is 70 mg/once daily (equivalent to 7 ml/once daily).
See prescribing info. for full details.
• Attention Deficit Hyperactivity Disorder (ADHD) in pts. ages 6 years and above.
• Mod. to Sev. Binge Eating Dis.(BED) for pts over 18 years.
C/I:Hypersens. Known hypersens. to amphetamine prod. Anaphylactic reactions, Stevens Johnson Syndrome, angioedema, and urticaria have been observed in post-marketing reports./Pts taking monoamine oxidase inhibit. (MAOIs), or within 14 days of stopping MAOIs (incl. MAOIs such as linezolid or intravenous methylene blue), because of an incr. risk of hypertensive crisis
NSAID. Flurbiprofen 8.75 mg. Spay solution,15 ml
One dose (3 actuations= 8.75 mg Flurbiprofen ) admin. to the back of the throat every 3-6 hs as required, up to a max. of 5 doses in 24 h
Short term symptomatic relief of acute sore throat in adults
C/I: Hypersens. /Pts with hypersens. reactions (e.g asthma, bronchospasm, rhinitis, angioedema or urticaria) to acetylsalicylic acid or other NSAIDs./Active, or hist. of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulcerat.) and intestinal ulcerat./Hist. of GI bleeding or perforation, sev. colitis, haemorrhagic or haematopoietic dis. related to previous NSAID ther./Last trim. of pregn. /Sev. HF, sev. renal fail. or sev. hepatic fail./Childr. and adolesc. below 18 years.
אנטרולקטון מגביר את יעילות גמציטבין בסרטן שחלה אפיתליאלי ומשפר דיסביוזה במעי
תוצאי שש פרקציות בשבוע בטיפול כימו-קרינתי בסרטן ראש-צוואר
סוג ומיקום של וריאנטים ב-BRCA1/2 והקשר לפרוגנוזה בסרטן השד
יעילות בדיקת Alinity m לזיהומים המועברים במגע מיני
כלי למניעת פוסט טראומה בחיילים: אימון הטיית קשב לפני לחימה
תוצאים פריאופרטיביים בשיטות שונות לכריתת ערמונית
פנוטיפים מולקולריים של ARDS: הבדלים ביולוגיים במערכת הנשימה התחתונה
טיפול נאו-אדג'ובנטי ואדג'ובנטי בחולי סרטן חודר שריר בשלפוחית השתן
שימוש בסטרואידים וסיכון לתופעות לוואי בסרטן ערמונית גרורתי הרגיש להורמונים
לעלון לצרכן לחצו כאן
הודעה על עדכון בעלון של התכשירים:
Cresemba 100 mg Capsules - לפרטים נוספים לחץ כאן
Cresemba 200 mg IV - לפרטים נוספים לחץ כאן
Ixifi - לפרטים נוספים לחץ כאן
Xanax X.R - לפרטים נוספים לחץ כאן
Diflucan 50mg/ml-לפרטים נוספים לחצו כאן
Trican 200 mg-לפרטים נוספים לחצו כאן
Triflucan I.V-לפרטים נוספים לחצו כאן
IXIFI-לפרטים נוספים לחצו כאן
Ferrous Gluconate 35 mg / 5 ml. SYR: 120 ml. Child: 4-6 mths: 2.5 ml dly;
6-12 mths: 5 ml dly. Over 1 yr: As reqd.
See lit.
Nutritional supplement.
CCB, Local Anesthetic. Lidocaine HCl 1.5%, Nifedipine 0.3%. RECTAL CR.: 30g. Should be applied twice dly. for at least 3 wks. See lit.
Tmt. of anal fissures and proctolog. general. associate. with anal sphincter hypertonia.
C/I: Hypersens. to the active ingred., partic. to Lidocaine (& other local anesthet. with a similar amidic type structure). Presumed or ascertained preg. & lact.
5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg. 5-a Reductase Inhibitor/Alpha 1 Blocker. Dutasteride 0.5 mg, tamsulosin 0.4 mg.
CAPS: 30. 1 cap. dly. See lit.
Tmt. mod. to severe symp. BPH. Reduc. risk of acute urin. reten. (AUR) and surgery in pts. with mod. to severe sympt. of BPH.
C/I: Hyperses., women, child., adolesn., pts. with a hist. of orthost. hypotension, pts. with severe hepat. impair.
Corticosteroid. Fluticasone Propionate 0.05%. METERED NASAL SPRAY: 120 doses. 2
sprays into ea. nostril 1 x dly. Child:
4-12 yrs: 1 spray into ea. nostril 1 x dly.
Under 4 yrs: Not recommended.
Proph. and tmt. seasonal allerg. rhinit.
incl. hayfever, perennial rhinit.
C/I: Hypersens. Concomitt. use with HIV drugs.
Histamine H1 Antagonist 2nd Generation. Bilastine 20 mg. TABS.: 20 mg. Adult. and adolesc. (12 yrs. of age and over) 1 tab×1/d for the relief of sympt. of allergic rhino-conjunctivit. (SAR and PAR) and urticaria. The tab. should be taken 1/2h. before after intake of food or fruit juice.
Indic. the symptom. tmt. of allerg. rhino-conjunctiv. (season. and perenn.) and urticaria in adult. and adolesc.(12 yrs. of age and over).
C/I: Hypersens.
NSAID. Ibuprofen 400 mg. CAPS. LIQUID FILL.: 20. For oral admin. and short term use only. Adult., the elder. and young persons over 12 yrs. of age: The min. effective dose should be used for the shortest time necessary to relieve sympt. If the product is requir. for more than 10 days or if the sympt. worsen, the pt. should consult a doctor.
If in child. or adolesc. betwn. 12 -18 yrs. of age, this med. product is require. for more than 3 days, or if sympt. worsen, a doctor should be consulted. 1 capsule up to 3 times a day, as require. The capsules should be taken with water.
Doses should be given approx. every 6-8 hrs., with a min. inter. of 4 hrs. between each dose. Do not take more than 1200 mg (3 caps.) in any 24 h. period. Not to be used for child. under 12 yrs. of age.
Relief of mild–moder. pain such as headache, pain assoc. with migraine, toothache, menstrual pain, backache, muscular pain, anti-inflamm. for rheumatic dis., reduct. of fever.
C/I: Hypersens. to ibuprofen. Pts. who have previous. shown hypersens. reactions (e.g. bronchospasm, asthma, rhinitis, angiodema or urticaria) in response to aspirin or other NSAID's. Active or previous peptic ulcer/haemorrhage (two or more distinct episodes of proven ulcer. or bleed). History of GI bleed. or perforation, related to previous NSAID ther. Cerebrovasc. bleed., other active bleed. or haematolog. dis. Severe hep. fail., severe renal fail. or severe HF. Use in third trim. of preg.
Corticosteroid, Vitamin D Analogue. Betamethasone (as dipropionate) 0.5 mg/g, Calcipotriol (as monohydrate) 50 mcg/g. ALUMINIUM CAN:60 g.
Enstilar foam should be applied to the affected area once dly. The recom. tmt. period is 4 wks. The dly. max. dose should not exceed 15 g, i.e. one 60 g can should last for at least 4 d. 15 g corresponds to the amount admin. from the can if the actuator is fully depressed for approx. one minute. A two-second application delivers approx. 0.5 g. As a guide, 0.5 g of foam should cover an area of skin roughly correspond. to the surface area of an adult hand. Concomit. use with other topic. products contain. calcipotriol in addition to Enstilar: the total dose of all calcipotriol contain. products should not exceed 15 g/d. The total bdy. surf. area treated should not exceed 30%.
Ren. / hep. impair. The safety and efficacy in pts. with severe renal insuffic. or severe Hep. disord. have not been evaluated.
Ped. population:The safety and efficacy in child. below 18 yrs. have not been establish. Enstilar is not indic. for child<18 yrs. of age.
Topical tmt. of psoriasis vulgaris in adults.
C/I: Hypersens.
Pts. with erythrodermic and pustular psorias.
Pts. with known calcium metabolism disord.
melatonin receptor agonists. Melatonin 1 mg, 5 mg. PR Tabs: 60 X 1 mg, 30 X 5mg. Recommend. Start. dose 2 mg. If inadeq. response observ., dose should be incr. to 5 mg, with a max. dose of 10 mg.
Drug should be taken once dly., 0.5-1 hr. before bedtime, with or after food.
Tmt. of insomnia in child. and adolesc. aged 2-18 with ASD and / or Smith-Magenis syndr., where sleep hygiene meas. have been insuff.
C/I: Hypersens.
SNRI. Duloxetine 30 , 60 mg. CAPS.:30. For diabet. peripher. neuropath. pain: The usual dose is 60 mg ×1/d.
For chron. musculoskel. pain and general. anxiety disord.: For most pts.
60 mg ×1/d. Some pts. require an init. dose of Dulox Teva 30 mg ×1/d for one wk., and then the usual dose of
60 mg ×1/d.
For depression: Most pts. will receive 60 mg ×1/d. Some pts. require an init. dose of Dulox Teva 30 mg ×1/d for one wk., and then the usual dose of 60 mg ×1/d
Elderly – The init. dose of 30 mg ×1/d for two wks., and only then consider incr. the dose to 60 mg ×1/d.
Fibromyalgia: The init. dose of Dulox Teva is 30 mg ×1/d for one wk., and then the usual dose of 60 mg ×1/d. In most cases, the effect of medication ther. with Dulox Teva is noticeab. after 2-4 wks. of tmt.
See lit.
Tmt. of major depressive episodes.
Managem. of neuropath.pain associat. with diabet. peripher. neuropathy.
Tmt. of generaliz. anxiety disord. (GAD).
Manag. of fibromyalgia.
Manag. of chron. muscoskel. pain when other therapies have failed or are
contraindic. This has been establish. in studies in pts. with chron. low back pain (CLBP) and chron. pain due to osteoarthritis.
C/I: Hypersens.
Pts. with hep. dis.
Pts. with severe ren. dis..
Concom. use with MAOI includ. IV methylene blue and the antibiot.linezolid. MAOI should be discount. 14 d. before init.of the tmt. with duloxetine.
Initiat. of MAOI should be start. at least 5 d. after discount. of the tmt. with duloxetine.
Concom. use with thioridazine
